You are here

GENESEGUES INC

Company Information
Address
3180 HIGH POINT DR
CHASKA, MN 55318-9476
United States


http://www.genesegues.com

Information

UEI: N/A

# of Employees: 5


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. TOPIC 313 PHASE I; RNAI CANCER THERAPEUTICS USING NANOTECHNOLOGY; HHSN2612013000

    Amount: $1,000,000.00

    The design, fabrication, characterization, and preclinical evaluation of novel nanoparticle-based drug formulations capable of delivering candidate RNAi therapeutics for the treatment of cancer.

    SBIRPhase II2014Department of Health and Human Services National Institutes of Health
  2. Therapy Management Software for Naturalistic Model-Based Behavioral Interventions

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): The ultimate goal of this project is to develop a safe and effective topical vaccine against the dengue virus (DENV). DENV causes an estimated 30 to 50 million cas ...

    SBIRPhase I2013Department of Health and Human Services National Institutes of Health
  3. TOPIC 313 PHASE I; RNAI CANCER THERAPEUTICS USING NANOTECHNOLOGY; HHSN2612013000

    Amount: $200,000.00

    The design, fabrication, characterization, and preclinical evaluation of novel nanoparticle-based drug formulations capable of delivering candidate RNAi therapeutics for the treatment of cancer. PUBLI ...

    SBIRPhase I2013Department of Health and Human Services National Institutes of Health
  4. Topical delivery of nanoencapsulated plasmid DNA to posterior ocular targets

    Amount: $158,983.00

    DESCRIPTION (provided by applicant): Diseases such as age related macular degeneration (AMD), other retinal dystrophies, and glaucoma cause a large proportion of blindness worldwide. A critical barrie ...

    SBIRPhase I2012Department of Health and Human Services National Institutes of Health
  5. Nonviral vehicles targeting liver cell-subtypes for nuclear delivery via rafts

    Amount: $406,030.00

    DESCRIPTION (provided by applicant): Despite recent advances, development of nucleic acid (NA) therapies continues to be impeded by the challenges of effective delivery. GeneSegues, Inc. (GSI) has dev ...

    SBIRPhase I2009Department of Health and Human Services National Institutes of Health
  6. SBIR TOPIC 251: DEVELOPMENT OF ANTICANCER AGENTS REQUESTOR: ALI ANDALIBI VEN

    Amount: $185,073.00

    Metastatic spread of cancer cells is the primary cause of death in cancer patients and developing therapeutic agents that kill primary and disseminated cancer cells is an important topic. The aim of t ...

    SBIRPhase I2008Department of Health and Human Services National Institutes of Health
  7. Tumor-targeted delivery of siRNA via sub-50 nanometer capsules

    Amount: $199,475.00

    DESCRIPTION (provided by applicant): The prospect of using siRNAs as potent inhibitors to any gene of choice may provide a new therapeutic approach for many intractable diseases. However, a major impe ...

    SBIRPhase I2006Department of Health and Human Services National Institutes of Health
  8. Nanocapsules for transposon therapy in cancer

    Amount: $69,883.00

    Viral vectors are used in more than 70% of current gene therapy trials. However, immunogenicity, oncogenicity, and poor tumor transfection efficiencies present significant barriers to clinical succes ...

    SBIRPhase I2005Department of Defense Army
  9. S50 nanocapsules for transcutaneous DNA vaccination

    Amount: $146,661.00

    DESCRIPTION (provided by applicant): The WHO estimates that 40 million individuals are infected with AIDS worldwide and that 16,000 new infections occur daily, lending continuing support for new appr ...

    SBIRPhase I2004Department of Health and Human Services National Institutes of Health
  10. Antisense gene therapy with tumor-targeted nanocapsules

    Amount: $245,059.00

    DESCRIPTION (provided by applicant): Antisense oligonucleotides have generated enormous interest as therapeutic molecules since their initial demonstration in 1978, but their full utilization as ef ...

    SBIRPhase I2003Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government